MX9800717A - Metodo para convertir una substancia medica, escasamente soluble en agua, a un estado amorfo. - Google Patents
Metodo para convertir una substancia medica, escasamente soluble en agua, a un estado amorfo.Info
- Publication number
- MX9800717A MX9800717A MX9800717A MX9800717A MX9800717A MX 9800717 A MX9800717 A MX 9800717A MX 9800717 A MX9800717 A MX 9800717A MX 9800717 A MX9800717 A MX 9800717A MX 9800717 A MX9800717 A MX 9800717A
- Authority
- MX
- Mexico
- Prior art keywords
- hardly soluble
- amorphous
- soluble medicine
- amorphism
- methods
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 3
- 239000007962 solid dispersion Substances 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 2
- 238000010438 heat treatment Methods 0.000 abstract 2
- 239000003381 stabilizer Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000007796 conventional method Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Treatment Of Sludge (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20593695 | 1995-08-11 | ||
| JP31040195 | 1995-11-29 | ||
| JP31040095 | 1995-11-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9800717A true MX9800717A (es) | 1998-11-30 |
Family
ID=27328563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9800717A MX9800717A (es) | 1995-08-11 | 1998-01-26 | Metodo para convertir una substancia medica, escasamente soluble en agua, a un estado amorfo. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6462093B1 (enExample) |
| EP (2) | EP1356807A3 (enExample) |
| KR (1) | KR100498813B1 (enExample) |
| CN (1) | CN1089232C (enExample) |
| AT (1) | ATE255405T1 (enExample) |
| AU (1) | AU702088B2 (enExample) |
| CA (1) | CA2228907A1 (enExample) |
| CZ (1) | CZ296072B6 (enExample) |
| DE (1) | DE69630964T2 (enExample) |
| MX (1) | MX9800717A (enExample) |
| NO (1) | NO320486B1 (enExample) |
| NZ (1) | NZ315089A (enExample) |
| TW (1) | TW487582B (enExample) |
| WO (1) | WO1997006781A1 (enExample) |
Families Citing this family (109)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1745774A3 (en) * | 1997-08-11 | 2007-04-11 | Pfizer Products Inc. | Solid pharmaceutical dispersions with enhanced bioavailability |
| EP0901786B1 (en) | 1997-08-11 | 2007-06-13 | Pfizer Products Inc. | Solid pharmaceutical dispersions with enhanced bioavailability |
| JPH11130698A (ja) * | 1997-10-31 | 1999-05-18 | Freunt Ind Co Ltd | アルギン酸多価金属塩球状微粒子集合体、該球状微粒子集合体に難溶性薬剤を担持した放出制御製剤及びそれらの製造方法 |
| IE980115A1 (en) * | 1998-02-16 | 2000-02-09 | Biovail Internat Ltd | Solubilizing delivery systems and method of manufacture |
| EP1027885B1 (en) | 1999-02-09 | 2008-07-09 | Pfizer Products Inc. | Basic drug compositions with enhanced bioavailability |
| EP1027887B1 (en) * | 1999-02-10 | 2008-08-13 | Pfizer Products Inc. | Matrix controlled release device |
| CA2362728C (en) | 1999-03-24 | 2009-06-23 | Fmc Corporation | Improved aqueous solubility pharmaceutical formulations |
| GB9920558D0 (en) * | 1999-08-31 | 1999-11-03 | Bradford Particle Design Ltd | Methods for particle formation and their products |
| ATE329579T1 (de) | 1999-11-12 | 2006-07-15 | Abbott Lab | Feste dispersion mit ritonavir, fenofibrat oder griseofulvin |
| US7364752B1 (en) | 1999-11-12 | 2008-04-29 | Abbott Laboratories | Solid dispersion pharamaceutical formulations |
| OA12124A (en) | 1999-12-23 | 2006-05-05 | Pfizer Prod Inc | Pharmmaceutical compositions providing enhanced drug concentrations. |
| DE10013289A1 (de) * | 2000-03-17 | 2001-09-20 | Knoll Ag | Torasemid enthaltende pharmazeutische Zubereitungen |
| DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
| US7115279B2 (en) | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| US20030086972A1 (en) * | 2000-08-09 | 2003-05-08 | Appel Leah E. | Hydrogel-driven drug dosage form |
| EP1308156A4 (en) * | 2000-08-11 | 2009-07-15 | Eisai R&D Man Co Ltd | AGGREGATE SOLID DISPERSION WITH IMPROVED SOLUBILITY |
| KR20020014570A (ko) * | 2000-08-18 | 2002-02-25 | 김충섭 | 고체분산화시킨 무정형 이프리플라본의 제조방법 |
| WO2002024168A1 (fr) * | 2000-09-25 | 2002-03-28 | Nippon Shinyaku Co., Ltd. | Procede de production d'une dispersion solide medicinale |
| US6482847B2 (en) * | 2000-10-03 | 2002-11-19 | Hoffmann-La Roche Inc. | Amorphous form of cell cycle inhibitor having improved solubility and bioavailability |
| EP1340496A4 (en) * | 2000-11-07 | 2004-04-14 | Hisamitsu Pharmaceutical Co | PHARMACEUTICAL PREPARATION OF THE PERCUTANEOUS ABSORPTION TYPE |
| US6977085B2 (en) | 2000-12-22 | 2005-12-20 | Baxter International Inc. | Method for preparing submicron suspensions with polymorph control |
| US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
| US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
| US6951656B2 (en) | 2000-12-22 | 2005-10-04 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
| US20050048126A1 (en) | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
| US6607784B2 (en) | 2000-12-22 | 2003-08-19 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
| US7193084B2 (en) | 2000-12-22 | 2007-03-20 | Baxter International Inc. | Polymorphic form of itraconazole |
| US6884436B2 (en) * | 2000-12-22 | 2005-04-26 | Baxter International Inc. | Method for preparing submicron particle suspensions |
| WO2002083101A1 (de) * | 2001-04-11 | 2002-10-24 | Bayer Aktiengesellschaft | Nimodipin-tablette mit kontrollierter freisetzung und verfahren zu deren herstellung |
| WO2003000235A1 (en) | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| EP1269994A3 (en) | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
| US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
| JP2005504090A (ja) | 2001-09-26 | 2005-02-10 | バクスター・インターナショナル・インコーポレイテッド | 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製 |
| US7112340B2 (en) | 2001-10-19 | 2006-09-26 | Baxter International Inc. | Compositions of and method for preparing stable particles in a frozen aqueous matrix |
| ITMI20012749A1 (it) | 2001-12-21 | 2003-06-21 | Chiesi Farma Spa | Procedimento per la preparazione mediante trattamento con microonde di composti di inclusione tra farmaco e ciclodestrine e prodotti ottenut |
| AU2003223158B2 (en) | 2002-01-09 | 2008-01-17 | Emisphere Technologies, Inc. | Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
| ATE395044T1 (de) | 2002-02-01 | 2008-05-15 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien |
| MY128945A (en) * | 2002-04-16 | 2007-03-30 | Kowa Co | Solid dispersion composition |
| DE10224170A1 (de) * | 2002-05-31 | 2003-12-11 | Desitin Arzneimittel Gmbh | Pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreisetzung |
| GB0216700D0 (en) * | 2002-07-18 | 2002-08-28 | Astrazeneca Ab | Process |
| US20040132771A1 (en) * | 2002-12-20 | 2004-07-08 | Pfizer Inc | Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors |
| ITMI20022748A1 (it) * | 2002-12-23 | 2004-06-24 | Eurand Int | Dispersioni solide stabilizzate di farmaco in un carrier organico e procedimento per la loro preparazione. |
| MXPA06001417A (es) | 2003-08-04 | 2006-05-15 | Pfizer Prod Inc | Composiciones farmaceuticas de adsorbatos de farmacos amorfos y materiales que forman microfases lipofilas. |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
| KR101138219B1 (ko) * | 2003-11-14 | 2012-04-24 | 아지노모토 가부시키가이샤 | 페닐알라닌 유도체의 고체 분산체 또는 고체 분산체 의약 제제 |
| US8535716B2 (en) * | 2004-04-01 | 2013-09-17 | Tsrl, Inc. | Methods and composition of extended delivery of water insoluble drugs |
| CA2561124A1 (en) * | 2004-04-08 | 2005-10-27 | Wyeth | Bazedoxifene acetate solid dispersion formulations |
| US7507823B2 (en) | 2004-05-06 | 2009-03-24 | Bristol-Myers Squibb Company | Process of making aripiprazole particles |
| ZA200700030B (en) * | 2004-06-08 | 2009-06-24 | Vertex Pharma | Pharmaceutical compositions |
| JP2006028130A (ja) * | 2004-07-21 | 2006-02-02 | Toa Eiyo Ltd | ピモベンダン経口投与製剤 |
| US7576216B2 (en) | 2004-07-30 | 2009-08-18 | Abbott Laboratories | Preparation of pyridonecarboxylic acid antibacterials |
| FR2875409B1 (fr) * | 2004-09-17 | 2010-05-07 | Sanofi Aventis | Composition pharmaceutique comprenant une dispersion solide a matrice polymere comprenant une phase continue de polydextrose et une phase continue d'un polymere autre que du polydextrose |
| CN101068546A (zh) * | 2004-10-06 | 2007-11-07 | 卫材R&D管理有限公司 | 医药组合物及其制造方法以及医药组合物中的二氢吡啶类化合物的稳定化方法 |
| CA2858733C (en) * | 2004-12-31 | 2017-12-19 | Iceutica Pty Ltd | Nanoparticle compositions and methods for synthesis thereof |
| KR20070100820A (ko) | 2005-01-31 | 2007-10-11 | 가부시키가이샤 바이오세렌택 | 경피 흡수 제제, 경피 흡수 제제 유지 시트 및 경피 흡수제제 유지 용구 |
| HRP20120502T1 (hr) * | 2005-04-11 | 2012-07-31 | Abbott@Laboratories | Farmaceutske smjese s poboljšanim profilom otapanja za slabo topljive lijekove |
| US9205046B2 (en) * | 2005-04-25 | 2015-12-08 | The Governing Council Of The University Of Toronto | Enhanced stability of inverse thermal gelling composite hydrogels |
| US9205047B2 (en) * | 2005-04-25 | 2015-12-08 | The Governing Council Of The University Of Toronto | Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix |
| WO2006118210A1 (ja) * | 2005-04-28 | 2006-11-09 | Eisai R & D Management Co., Ltd. | ジヒドロピリジン系化合物の分解を防止する方法 |
| WO2006128288A1 (en) * | 2005-06-02 | 2006-12-07 | Thallion Pharmaceuticals Inc. | Formulation comprising farnesyl dibenzodiazepinone and a pharmaceutically acceptable surfactant |
| WO2007016435A2 (en) * | 2005-07-28 | 2007-02-08 | Isp Investments Inc. | Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced |
| JP4974018B2 (ja) * | 2005-08-24 | 2012-07-11 | オリンパステルモバイオマテリアル株式会社 | 生体材料とその製造方法 |
| PT1926476E (pt) * | 2005-08-29 | 2013-07-10 | Sanofi Aventis Us Llc | Dispersões sólidas amorfas de 7-cloro-n,n,5-trimetil-4-oxo-3- fenil-3,5-di-hidro-4h-piridazino[4,5-b]indole-1-acetamida |
| EP2000152A4 (en) | 2006-03-23 | 2013-01-23 | Shionogi & Co | SOLID PREPARATION WITH IMPROVED SOLUBILITY |
| US20080085315A1 (en) * | 2006-10-10 | 2008-04-10 | John Alfred Doney | Amorphous ezetimibe and the production thereof |
| WO2008076780A2 (en) * | 2006-12-14 | 2008-06-26 | Isp Investments Inc. | Amorphous valsartan and the production thereof |
| US8613946B2 (en) * | 2006-12-21 | 2013-12-24 | Isp Investment Inc. | Carotenoids of enhanced bioavailability |
| WO2008092046A2 (en) * | 2007-01-26 | 2008-07-31 | Isp Investments Inc. | Amorphous oxcarbazepine and the production thereof |
| WO2008092057A2 (en) * | 2007-01-26 | 2008-07-31 | Isp Investments Inc. | Formulation process method to produce spray dried products |
| KR20100016093A (ko) * | 2007-03-30 | 2010-02-12 | 아지노모토 가부시키가이샤 | 고체 분산체 제제 |
| US8703204B2 (en) | 2007-05-03 | 2014-04-22 | Bend Research, Inc. | Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer |
| WO2008135828A2 (en) | 2007-05-03 | 2008-11-13 | Pfizer Products Inc. | Nanoparticles comprising a drug, ethylcellulose, and a bile salt |
| US8426467B2 (en) | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
| US8722736B2 (en) | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
| WO2008149230A2 (en) | 2007-06-04 | 2008-12-11 | Pfizer Products Inc. | Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate |
| EP2162120B1 (en) | 2007-06-04 | 2016-05-04 | Bend Research, Inc | Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer |
| KR101443826B1 (ko) | 2007-06-14 | 2014-09-23 | 가부시키가이샤 폴라 파마 | 의약조성물 |
| EP2030613A1 (en) | 2007-08-17 | 2009-03-04 | Abbott GmbH & Co. KG | Preparation of compositions with essentially noncrystalline embedded macrolide antibiotics |
| JPWO2009038112A1 (ja) * | 2007-09-21 | 2011-01-06 | 塩野義製薬株式会社 | Ｎｐｙｙ５受容体拮抗剤を含有する固形製剤 |
| WO2009073216A1 (en) | 2007-12-06 | 2009-06-11 | Bend Research, Inc. | Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer |
| US9724362B2 (en) | 2007-12-06 | 2017-08-08 | Bend Research, Inc. | Pharmaceutical compositions comprising nanoparticles and a resuspending material |
| US20110065800A1 (en) | 2008-05-14 | 2011-03-17 | Haihong Fan | Formulations for cathepsin k inhibitors |
| US20100159001A1 (en) * | 2008-12-19 | 2010-06-24 | Cardinal John R | Extended-Release Pharmaceutical Formulations |
| US20100160363A1 (en) * | 2008-12-19 | 2010-06-24 | Aaipharma Services Corp. | Extended-release pharmaceutical formulations |
| CN102438623A (zh) * | 2009-03-19 | 2012-05-02 | 盐野义制药株式会社 | 含有npyy5受体拮抗剂的固体制剂 |
| MY159208A (en) | 2009-04-24 | 2016-12-30 | Iceutica Pty Ltd | A novel formulation of indomethacin |
| CN101618012B (zh) * | 2009-07-10 | 2012-07-04 | 东华大学 | 一种难溶性药物固体分散体制备方法 |
| FR2954771B1 (fr) * | 2010-04-23 | 2013-09-13 | Mohamed Skiba | Nouveau procede de synthese de copolymeres, terpolymeres et tetrapolymeres de cyclodextrines et leurs utilisations |
| ES2511145T3 (es) * | 2010-10-14 | 2014-10-22 | Abbott Gmbh & Co. Kg | Formulación de dispersión sólida de curcuminoides |
| US20130237609A1 (en) * | 2011-10-19 | 2013-09-12 | Kevin J. Edgar | Cellulose derivatives for enhancing bioavailability of flavonoids |
| JP5909796B2 (ja) * | 2012-03-02 | 2016-04-27 | 株式会社サンギ | 難溶性物質の水溶解性改善方法 |
| KR20150038212A (ko) * | 2012-07-23 | 2015-04-08 | 다우 글로벌 테크놀로지스 엘엘씨 | 경질 캡슐 쉘용 필름 조성물 |
| KR101986683B1 (ko) * | 2012-12-13 | 2019-06-10 | 한미약품 주식회사 | 테트라졸 유도체를 활성 성분으로 포함하는 용해도가 개선된 고체 분산체 |
| CN103191077B (zh) * | 2013-04-18 | 2014-08-20 | 广东彼迪药业有限公司 | 一种格列齐特片及其制备方法 |
| EP2832723B1 (en) * | 2013-07-29 | 2017-02-15 | Zentiva, a.s. | Stabilised amorphous forms of Saxagliptin |
| JP2015189677A (ja) * | 2014-03-27 | 2015-11-02 | テバ製薬株式会社 | ソリフェナシン非晶質体を含有する医薬組成物 |
| KR20170005007A (ko) | 2014-05-15 | 2017-01-11 | 테라벨류스 코포레이션 | 경구 섭취용 조성물 |
| US9526734B2 (en) | 2014-06-09 | 2016-12-27 | Iceutica Pty Ltd. | Formulation of meloxicam |
| CN106793821B (zh) * | 2014-08-29 | 2021-05-07 | 花王株式会社 | 含有难溶性多酚类的固体分散体的制造方法 |
| EP3267977B1 (en) * | 2015-03-12 | 2021-08-11 | DuPont Nutrition USA, Inc. | Solid dispersions |
| CN107920528A (zh) * | 2015-09-04 | 2018-04-17 | 住友化学株式会社 | 组合物、组合物的制造方法和农药组合物 |
| KR101912224B1 (ko) * | 2017-02-20 | 2018-10-26 | 충남대학교산학협력단 | 타다라필 함유 고체 분산체, 이를 포함하는 약제학적 조성물 및 이의 제조방법 |
| WO2019172420A1 (ja) * | 2018-03-09 | 2019-09-12 | 協和発酵キリン株式会社 | 医薬組成物 |
| CN111184692B (zh) * | 2020-02-14 | 2021-10-26 | 南京大渊医美生物技术有限公司 | 一种白藜芦醇的制剂及其制备方法 |
| CN111803447B (zh) * | 2020-06-22 | 2022-08-09 | 三明学院 | 一种制备无定形药物的方法 |
| WO2022090295A1 (en) * | 2020-10-28 | 2022-05-05 | Merck Patent Gmbh | Method for producing an amorphous solid dispersion and pharmaceutical composition for stabilizing active pharmaceutical ingredients |
| CN113350309B (zh) * | 2021-08-09 | 2021-11-12 | 北京五和博澳药业股份有限公司 | 一种难溶性药物渗透泵控释片剂及其制备方法 |
| CN117257964B (zh) * | 2023-10-25 | 2024-04-02 | 苏州大学 | 基于碳酸氢铵的微波诱导吲哚美辛原位无定形化增溶技术 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2373049A (en) * | 1943-02-05 | 1945-04-03 | Du Pont | Stabilization of organic substances |
| US4083814A (en) * | 1976-12-16 | 1978-04-11 | General Electric Company | Polycarbonate compositions plasticized with urea compounds |
| GB1579818A (en) * | 1977-06-07 | 1980-11-26 | Yamanouchi Pharma Co Ltd | Nifedipine-containing solid preparation composition |
| CA1146866A (en) * | 1979-07-05 | 1983-05-24 | Yamanouchi Pharmaceutical Co. Ltd. | Process for the production of sustained release pharmaceutical composition of solid medical material |
| JPS6038322A (ja) * | 1983-08-11 | 1985-02-27 | Fujisawa Pharmaceut Co Ltd | ジヒドロピリジンａ物質含有易溶性固形製剤 |
| US4695591A (en) * | 1985-03-29 | 1987-09-22 | Schering Corporation | Controlled release dosage forms comprising hydroxypropylmethylcellulose |
| US4704285A (en) * | 1985-11-18 | 1987-11-03 | The Dow Chemical Company | Sustained release compositions comprising hydroxypropyl cellulose ethers |
| CH668187A5 (de) * | 1986-08-07 | 1988-12-15 | Ciba Geigy Ag | Therapeutisches system mit systemischer wirkung. |
| SE8604117D0 (sv) * | 1986-09-29 | 1986-09-29 | Kabivitrum Ab | Composition |
| JPS63115815A (ja) | 1986-10-31 | 1988-05-20 | Mitsubishi Kasei Corp | 肝疾患治療薬組成物 |
| WO1988003023A1 (fr) * | 1986-10-31 | 1988-05-05 | Mitsubishi Chemical Industries Limited | Composition de medicament contre les maladies du foie et procede de preparation |
| US5510115A (en) * | 1987-11-16 | 1996-04-23 | Baxter Travenol Laboratories, Inc. | Method and composition for administration of beneficial agent by controlled dissolution |
| US4855380A (en) * | 1987-12-16 | 1989-08-08 | General Electric Company | Cyclopentadiene-containing cyclic polycarbonate oligomer |
| US5211957A (en) * | 1988-03-25 | 1993-05-18 | Ciba-Geigy Corporation | Solid rapidly disintegrating dosage form |
| JP2528706B2 (ja) * | 1988-05-30 | 1996-08-28 | ゼリア新薬工業株式会社 | ジヒドロピリジン化合物の製剤組成物 |
| JPH01305616A (ja) * | 1988-06-02 | 1989-12-08 | Toshiba Corp | 半導体集積回路の出力回路 |
| JP2750130B2 (ja) | 1988-08-31 | 1998-05-13 | 日清製粉株式会社 | 経口投与用組成物 |
| ES2111065T5 (es) | 1991-04-16 | 2005-06-16 | Nippon Shinyaku Company, Limited | Procedimiento para producir una dispersion solida. |
| US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
| US5340591A (en) | 1992-01-24 | 1994-08-23 | Fujisawa Pharmaceutical Co., Ltd. | Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine |
| JP2516524B2 (ja) | 1992-04-27 | 1996-07-24 | 大洋薬品工業株式会社 | 持続性製剤 |
| ES2138070T3 (es) * | 1992-12-23 | 2000-01-01 | Saitec Srl | Proceso para la preparacion de formas farmaceuticas de liberacion controlada y las formas obtenidas de esta manera. |
| DK19393D0 (da) | 1993-02-19 | 1993-02-19 | Danochemo As | Fremgangsmaade til fremstilling af et i vand dispergerbart pulverformigt carotenoidpraeparat |
| NO933375L (no) * | 1993-02-24 | 1994-08-25 | Marcus Kjemiske As Thor | Vaskemiddelblanding |
| JPH0717866A (ja) * | 1993-06-16 | 1995-01-20 | Meiji Seika Kaisha Ltd | 医薬組成物 |
| DE69411276T2 (de) * | 1993-09-23 | 1998-11-26 | E.I. Du Pont De Nemours And Co., Wilmington, Del. | Körnige wasserdispergierbare landwirtschaftliche zusammensetzung hergestellt durch strangpressen mit wärme |
| IL139728A (en) * | 1995-01-09 | 2003-06-24 | Penwest Pharmaceuticals Compan | Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient |
| US5705190A (en) * | 1995-12-19 | 1998-01-06 | Abbott Laboratories | Controlled release formulation for poorly soluble basic drugs |
-
1996
- 1996-08-07 TW TW085109577A patent/TW487582B/zh not_active IP Right Cessation
- 1996-08-08 DE DE69630964T patent/DE69630964T2/de not_active Expired - Lifetime
- 1996-08-08 NZ NZ315089A patent/NZ315089A/xx unknown
- 1996-08-08 CN CN96196203A patent/CN1089232C/zh not_active Expired - Fee Related
- 1996-08-08 EP EP03016608A patent/EP1356807A3/en not_active Withdrawn
- 1996-08-08 EP EP96926600A patent/EP0852140B1/en not_active Expired - Lifetime
- 1996-08-08 KR KR1019980700496A patent/KR100498813B1/ko not_active Expired - Fee Related
- 1996-08-08 WO PCT/JP1996/002246 patent/WO1997006781A1/ja not_active Ceased
- 1996-08-08 CA CA002228907A patent/CA2228907A1/en not_active Abandoned
- 1996-08-08 AT AT96926600T patent/ATE255405T1/de not_active IP Right Cessation
- 1996-08-08 US US09/011,060 patent/US6462093B1/en not_active Expired - Fee Related
- 1996-08-08 CZ CZ0032698A patent/CZ296072B6/cs not_active IP Right Cessation
- 1996-08-08 AU AU66693/96A patent/AU702088B2/en not_active Ceased
-
1998
- 1998-01-26 MX MX9800717A patent/MX9800717A/es not_active IP Right Cessation
- 1998-02-09 NO NO19980549A patent/NO320486B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO980549D0 (no) | 1998-02-09 |
| DE69630964D1 (de) | 2004-01-15 |
| DE69630964T2 (de) | 2004-10-28 |
| JPWO9706781A1 (enExample) | 1997-02-27 |
| KR100498813B1 (ko) | 2006-02-28 |
| CZ32698A3 (cs) | 1998-06-17 |
| KR19990035836A (ko) | 1999-05-25 |
| ATE255405T1 (de) | 2003-12-15 |
| WO1997006781A1 (en) | 1997-02-27 |
| EP0852140B1 (en) | 2003-12-03 |
| NO980549L (no) | 1998-04-02 |
| AU6669396A (en) | 1997-03-12 |
| EP0852140A1 (en) | 1998-07-08 |
| US6462093B1 (en) | 2002-10-08 |
| EP1356807A3 (en) | 2004-01-28 |
| AU702088B2 (en) | 1999-02-11 |
| CZ296072B6 (cs) | 2006-01-11 |
| NO320486B1 (no) | 2005-12-12 |
| CA2228907A1 (en) | 1997-02-27 |
| NZ315089A (en) | 1999-06-29 |
| TW487582B (en) | 2002-05-21 |
| CN1192677A (zh) | 1998-09-09 |
| CN1089232C (zh) | 2002-08-21 |
| EP0852140A4 (enExample) | 1998-07-29 |
| EP1356807A2 (en) | 2003-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9800717A (es) | Metodo para convertir una substancia medica, escasamente soluble en agua, a un estado amorfo. | |
| AU1682895A (en) | Thermally inhibited starches and flours and process for their production | |
| EP1165621B8 (fr) | Polymeres de cyclodextrine(s) et/ou derives de cyclodextrine(s) presentant des proprietes complexantes et echangeuses d'ions et leur procede de fabrication | |
| AU695352B2 (en) | Process for producing derivatives of 4a,5,9,10,11,12,-hexahydro-6h-benzofuro{3a,3,2-ef}{2} benzazepine | |
| EP0982378A4 (en) | RUSS AND METHOD FOR THE PRODUCTION THEREOF | |
| CA2405917A1 (en) | Molybdenum metal and production thereof | |
| MX9801855A (es) | Proceso para la produccion de difluorometano. | |
| ATE342142T1 (de) | Verfahren zur behandlung metallischer werkstoffe | |
| HUP9600334A3 (en) | Process for producing emulgator-free aqueous polymer dispersions | |
| AU1754399A (en) | Method for producing water-soluble or water-swellable polymerizates with a very low residual monomer content, products produced according to this method and the use thereof | |
| IL115301A (en) | Process for the manufacture of amylopectin breakdown products | |
| EP0821886A3 (en) | Method of providing aromatic compounds from tobacco | |
| FI971932A0 (fi) | Menetelmä pesu- ja puhdistusainetablettien valmistamiseksi mikroaalto- ja kuumailmakäsittelyllä | |
| EP0867442A3 (en) | A process for treating methylchlorosilanes by-products | |
| EP0739912A3 (en) | Polymers with a high acid value, their use and process for their preparation | |
| NO20022163L (no) | Fremgangsmåte for fremstilling av ekspanderte leiregranulater | |
| MY133701A (en) | A method for producing octahydrofluorenyl metal complexes. | |
| IL137003A0 (en) | Method for producing doxazodin mesylate in a crystal modification designated as form a and intermediate product for producing the same | |
| HU9801504D0 (en) | Cooking aid of the lump type, process for producing of that and apparatus for carrying out of the process | |
| IL151926A0 (en) | Drug for stimulating leucopoiesis and for treating tumour diseases, protozoal diseases, acariasis and arthropodiasis, and process for producing it | |
| ES465914A1 (es) | Procedimiento para preparar tiazolina-2-tionas. | |
| ZA9610842B (en) | Iminooxyphenyl acetic acid derivatives, process and intermediaries for their production and their use. | |
| MY130951A (en) | Process for producing lactoprotein-containing acidified beverage | |
| GB9709449D0 (en) | Low temperature production of metal oxides | |
| DE60021606D1 (de) | Verfahren und vorrichtung zum biegen von glass |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |